Which stock is cheaper: SUNPHARMA or CIPLA?

Based on Price to Earnings, SUNPHARMA trades at a P/E of 36.1 while CIPLA trades at a P/E of 32.3.

Does SUNPHARMA or CIPLA have higher ROCE?

SUNPHARMA generates an ROCE of 22.1% compared to CIPLA's ROCE of 15.9%.

SUN PHARMACEUTICAL IND L (SUNPHARMA) has a market cap of ₹4,41,478 Cr compared to CIPLA LTD (CIPLA) with ₹1,10,353 Cr.

SUNPHARMAHealthcare

₹1,777.70+0.95%

Market Cap: ₹4,41,478 Cr

CIPLAHealthcare

Leads (3/5)

₹1,378.90+1.54%

Market Cap: ₹1,10,353 Cr

Automated quantitative breakdown of fundamental strengths between SUNPHARMA and CIPLA.

Attractive ValuationCIPLA (P/E 32.3)Trades at lower Price-to-Earnings

Capital EfficiencySUNPHARMA (ROCE 22.1%)Superior operating return on capital

Balance Sheet SafetyCIPLALower debt-to-equity ratio

Shareholder YieldCIPLA (6.82%)Higher annual dividend yield

Green highlight indicates the stronger metric

Financial Metric	SUNPHARMA	CIPLA
Valuation Multiples
Market Capitalization	₹4,41,478 Cr	₹1,10,353 Cr
Price to Earnings (P/E)	36.07	32.32
Price to Book (P/B)	19.73	3.23
Profitability & Capital Efficiency
Return on Capital Employed (ROCE)	22.11%	15.89%
Return on Equity (ROE)	12.96%	11.12%
Operating Profit Margin (OPM)	27.39%	16.22%
Net Profit Margin (NPM)	12.40%	23.17%
Balance Sheet & Solvency
Debt to Equity Ratio	0.61	0.00
Dividend Yield	4.84%	6.82%
Historical Growth
3-Year Sales Growth (CAGR)	11.41%	1.84%
Latest Quarter Financial Results
Quarterly Revenue (30 Jun 2026)	₹15,184 Cr	₹7,077 Cr
Quarterly Net Profit	₹2,895 Cr	₹789 Cr